The fact that the dysregulation of the ureagenic cycle represents a distinctive feature of ccRCC is supported by the low levels of mRNA and the altered expression and function of representative enzymes (ASS1, ASL, ARG2) in tumour samples compared to normal kidney tissue [46]. This evidence concerns the gene ASS1 and nonpapillary renal cell carcinoma.